微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 3.96% | -17.33% | 101.02% | 32/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | 1.97% | -16.53% | -77.84% | 38/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 8.89% | 3.86% | 21.12% | 23/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 7.34% | 10.04% | 53.24% | 29/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 4.79% | 14.32% | 102.97% | 27/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 2.36% | -5.22% | -72.43% | 37/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 8.56% | -11.39% | 28.34% | 39/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 6.67% | -16.94% | 59.19% | 46/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 4.19% | -25.04% | 68.27% | 46/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 2.49% | -33.6% | -74.22% | 40/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 9.66% | -28.6% | 20.3% | 34/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 8.03% | -30.78% | 43.65% | 43/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 5.59% | -30.13% | 49.07% | 39/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 3.75% | 11.61% | -72.28% | 30/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 13.53% | -3.15% | 16.64% | 47/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 11.6% | 1.75% | 45% | 49/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 8% | 27.39% | 138.1% | 44/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 3.36% | 31.76% | -75.95% | 47/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 13.97% | 25.63% | 22.54% | 62/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 11.4% | 25.97% | 81.53% | 52/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 6.28% | 22.42% | 146.27% | 67/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 2.55% | 31.44% | -77.07% | 60/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 11.12% | 18.05% | 22.87% | 84/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 9.05% | 9.17% | 76.41% | 55/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 5.13% | 1.99% | 164.43% | 71/141 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 1.94% | -13.78% | -79.41% | 41/141 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 9.42% | -9.77% | 13.63% | 80/141 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 8.29% | -6.96% | 64.81% | 38/141 | 10.54% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 5.03% | 4.36% | 123.56% | 45/141 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 2.25% | 14.21% | -78.45% | 29/141 | 2.73% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 10.44% | 14.98% | 17.17% | 68/141 | 14.23% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 8.91% | 15.71% | 84.85% | 30/141 | 9.71% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 4.82% | 12.62% | 144.67% | 29/141 | 4.54% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 1.97% | -5.29% | -78.3% | 31/141 | 2.78% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 9.08% | -32.44% | 17.92% | 69/141 | 14.51% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 7.7% | -28.1% | 79.91% | 29/141 | 9.49% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 4.28% | -31.85% | 105.77% | 37/141 | 6.11% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 2.08% | 2% | -84.52% | 24/141 | 2.74% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 13.44% | 3.78% | 25.49% | 43/141 | 16.44% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 10.71% | 2% | 70.54% | 14/141 | 8.86% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 6.28% | 2.45% | -51.51% | 20/141 | 6.35% | *ST明德 | 23.29% | 行业排名> |